Biofil Chemicals & Pharmaceuticals Ltd: Trading Window Closed Until 48 Hours After Q4 and FY26 Results
Biofil Chemicals & Pharmaceuticals Ltd has announced the closure of the trading window for all designated persons, their immediate relatives, and connected persons. The closure is effective from April 01, 2026, and is in accordance with the Company's Code of Conduct and SEBI regulations. The trading window will reopen 48 hours after the audited financial results for the quarter and financial year ended March 31, 2026, are generally available. Directors, KMP’s, Designated Employees, Connected Persons, Fiduciaries, and their immediate relatives are advised not to deal in the securities of the Company during the closure period. The date of the Board Meeting for the purpose of consideration of Audited Financial Results for the Quarter and Financial Year ended March 31, 2026, will be intimated in due course.
Key Highlights
- Trading window closed for designated persons and their relatives until 48 hours after Q4 and FY26 results
- Closure in accordance with the Company's Code of Conduct and SEBI regulations
- Trading window to reopen 48 hours after results are generally available
- Directors, KMP’s, Designated Employees, Connected Persons, Fiduciaries, and their immediate relatives advised not to deal in the securities during the closure period
- Date of Board Meeting for consideration of Audited Financial Results to be intimated later
Price Impact
More from BIOFILCHEM